Microbial deglycosylation and ketonization of ginsenoside by Cladosporium cladosporioide and their anticancer activity

Antonie van Leeuwenhoek, International Journal of General and Molecular Microbiology

Volumn 109, Issue 2, 2016, Pages 179-185

  Jin, Yan ^a   Jung, Sun Young ^a   Kim, Yeon Ju ^a   Lee, Dae Young ^b   Aceituno, Verónica Castro ^a   Wang, Chao ^a   Yang, Deok Chun ^a  

^a Kyung Hee University   (South Korea)

^b Rural Development Administration   (South Korea)

Author keywords

Anticancer; Ginseng; Ginsenoside; Ketonization; Transformation

Indexed keywords

12BETA HYDROXYDAMMAR 3 ONE 20 O BETA DEXTRO GLUCOPYRANOSIDE; DAMMAR 24 EN 12BETA,20 DIOL 3 ONE; GINSENOSIDE; GINSENOSIDE CK; GINSENOSIDE F2; GINSENOSIDE PPD; GINSENOSIDE RB 1; GINSENOSIDE RD; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

A549 CELL LINE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CARBON NUCLEAR MAGNETIC RESONANCE; CELL PROLIFERATION; CHEMICAL MODIFICATION; CLADOSPORIUM CLADOSPORIOIDE KACC 43926; CONTROLLED STUDY; DEGLYCOSYLATION; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG ISOLATION; DRUG METABOLISM; DRUG POTENCY; DRUG STRUCTURE; FUNGAL STRAIN; FUNGUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; KETONIZATION; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SOLVENT EXTRACTION; BIOTRANSFORMATION; CHEMICAL STRUCTURE; CHEMISTRY; CLADOSPORIUM; DRUG EFFECTS; GLYCOSYLATION; METABOLISM; MICROBIOLOGY; PANAX; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOTRANSFORMATION; CELL LINE, TUMOR; CELL PROLIFERATION; CLADOSPORIUM; GINSENOSIDES; GLYCOSYLATION; HUMANS; MOLECULAR STRUCTURE; PANAX;

EID: 84957977508     PISSN: 00036072     EISSN: 15729699     Source Type: Journal    
DOI: 10.1007/s10482-015-0619-8     Document Type: Article

References (35)

1. Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K (1998) Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J Pharm Pharmacol 50:1155–1160
2. Ang-Lee MK, Moss J, Yuan CS (2001) Herbal medicines and perioperative care. JAMA 286:208–216
3. Anufriev VP, Malinovskaya GV, Denisenko VA, Uvaròva NI, Elyakov GB, Kim SI, Baek NI (1997) Synthesis of ginsenoside Rg3, a minor constituent of Ginseng Radix. Carbohydr Res 304:179–182
4. Asakawa J, Kasai R, Yamasaki K, Tanaka O (1977) Carbon-13 NMR study of Ginseng sapogenins and their related dammarane type triterpenes. Tetrahedron 33:1935–1939
5. Attele AS, Wu JA, Yuan CS (1999) Ginseng pharmacology: multiple constituents and multiple actions. Bioche Pharmacol 58:1685–1693
6. Bae EA, Han MJ, Kim EJ, Kim DH (2004) Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Arch Pharm Res 27:61–67
7. Cao B, Qi Y, Yang Y, Liu X, Xu D, Guo W, Zhan Y, Xiong Z, Zhang A, Wang AR, Fu X, Zhang H, Zhao L, Gu J, Dong Y (2014) 20(S)-protopanaxadiol inhibition of progression and growth of castration-resistant prostate cancer. Plos One 9:e111201
8. Chen G, Yang M, Song Y, Lu Z, Zhang J, Huang H, Guan S, Wu L, Guo DA (2008) Comparative analysis on microbial and rat metabolism of ginsenoside Rb1 by high-performance liquid chromatography coupled with tandem mass spectrometry. Biomed Chromatogr 22:779–785
9. Chen G, Yang M, Nong S, Yang X, Ling Y, Wang D, Wang X, Zhang W (2013) Microbial transformation of 20(S)-protopanaxadiol by Absidia corymbifera. Cytotoxic activity of the metabolites against human prostate cancer cells. Fitoterapia 84:6–10
10. Cheng LQ, Na JR, Bang MH, Kim MK, Yang DC (2008) Conversion of major ginsenoside Rb1 to 20(S)-ginsenoside Rg3 by Microbacterium sp. GS514. Phytochemistry 69:218–224
11. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917
12. Gong HC, Wang S, Mayer G, Chen G, Leesman G, Singh S, Beer DG (2011) Signatures of drug sensitivity in nonsmall cell lung cancer. Int J Proteomics 2011:215496
13. Ha YW, Ahn KS, Lee JC, Kim SH, Chung BC, Choi MH (2010) Validated quantification for selective cellular uptake of ginsenosides on MCF-7 human breast cancer cells by liquid chromatography-mass spectrometry. Anal Bioanal Chem 396:3017–3025
14. Hasegawa H (2004) Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci 95:153–157
15. Hasegawa H, Sung JH, Matsumiya S, Uchiyama M (1996) Main ginseng metabolites formed by intestinal bacteria. Planta Med 62:453–455
16. Jeong A, Lee HJ, Jeong SJ, Lee HJ, Lee EO, Bae H, Kim SH (2010) Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of p38 mitogen activated protein kinase and AKT in human umbilical vein endothelial cells. Bio Pharm Bull 33:945–950
17. Jin X, Li SL, Zhang ZH, Zhu FX, Sun E, Wei YJ, Jia XB (2013) Characterization of metabolites of 20(S)-protopanaxadiol in rats using ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry. J Chromatogr B 933:59–66
18. Jin Y, Jung SY, Kim YJ, Lee DY, Min JW, Wang C, Yang DC (2014) Microbial ketonization of ginsenosides F1 and C-K by Lactobacillus brevis. Antonie Van Leeuwenhoek 106:1215–1221
19. Joh EH, Lee IA, Jung IH, Kim DH (2011) Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation–the key step of inflammation. Biochem Pharmacol 82:278–286
20. Kim DY, Park MW, Yuan HD, Lee HJ, Kim SH, Chung SH (2009) Compound K induces apoptosis via CAMK-IV/AMPK pathways in HT-29 colon cancer cells. J Agric Food Chem 57:10573–10578
21. Lee HU, Bae EA, Han MJ, Kim NJ, Kim DH (2005) Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury. Liver Int 25:1069–1073
22. Liu X, Qiao LR, Xie D, Dai JG (2011) Microbial deglycosylation and ketonization of ginsenosides Rg1 and Rb1 by Fusarium oxysporum. J Asian Nat Prod Res 13:652–658
23. Ming Y, Chen Z, Chen L, Lin D, Tong Q, Zheng Z, Song G (2011) Ginsenoside compound K attenuates metastatic growth of hepatocellular carcinoma, which is associated with the translocation of nuclear factor-κB p65 and reduction of matrix metalloproteinase-2/9. Planta Med 77:428–433
24. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
25. Quan LH, Piao JY, Min JW, Yang DU, Lee HN, Yang DC (2011) Bioconversion of ginsenoside Rb1 into compound k by Leuconostoc citreum LH1 isolated from kimchi. Braz J Microbiol 42:1227–1237
26. Rumney CJ, Rowland IR (1992) In vivo and in vitro models of the human colonic flora. Crit Rev Food Sci Nutr 31:299–331
27. Shibata S, Tanaka O, Soma K, Ando T, Iida Y, Nakamura H (1965) Studies on saponins and sapogenins of ginseng: the structure of panaxatriol. Tetrahedron Lett 42:207–213
28. Simon GL, Gorbach SL (1986) The human intestinal microflora. Dig Dis Sci 31:147–162
29. Son JW, Kim HJ, Oh DK (2008) Ginsenoside Rd production from the major ginsenoside Rb1 by beta-glucosidase from Thermus caldophilus. Biotechnol Lett 30:713–716
30. Sun BS, Gu LJ, Fang ZM, Wang CY, Wang Z, Lee MR, Li Z, Li JJ, Sung CK (2009) Simultaneous quantification of 19 ginsenosides in black ginseng developed from Panax ginseng by HPLC-ELSD. J Pharm Biomed Anal 50:15–22
31. Wakabayashi C, Hasegawa H, Murata J, Saiki I (1997) In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oncol Res 9:411–417
32. Wu LP, Jin Y, Yin CR, Bai LL (2012) Co-transformation of Panax major ginsenosides Rb1 and Rg1 to minor ginsenosides C-K and F1 by Cladosporium cladosporioides. J Ind Microbiol Biotechnol 39:521–527
33. Yang L, He KJ, Y. Yang (2003) A preparation method of less polar individual ginsenosides and saponins by base hydrolysis. China Patent CN03134090.3
34. Yang WZ, Hu Y, Wu WY, Ye M, Guo DA (2014) Saponins in the genus Panax L. (Araliaceae): a systematic review of their chemical diversity. Phytochemistry 106:7–24
35. Zhang YL, Zhang R, Xu HL, Yu XF, Qu SC, Sui DY (2013) 20(S)-protopanaxadiol triggers mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via inhibiting the PI3 K/Akt signaling pathway. Am J Chin Med 41:1137–1152